Allergan Rips Valeant's Biz Model As Heftier Bid Looms
Allergan Inc. on Tuesday attacked Valeant Pharmaceuticals International Inc.'s management and business strategy, criticism that adds to ongoing discord between the companies and comes just one day before Valeant and activist...To view the full article, register now.
Already a subscriber? Click here to view full article